Rheumatology
News
FDA approves Taltz for treatment of ankylosing spondylitis
The approval is based on results from a pair of randomized, double-blind, placebo-controlled, phase 3 studies involving 657 adult patients with...
Conference Coverage
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patients
EULAR’s updated guidance on vaccinations for patients with AIIRD starts with an annual status assessment.
Conference Coverage
Digital health and big data: New tools for making the most of real-world evidence
Digital health technology offers new approaches and possibilities for generating and harnessing the power of real-world evidence for improving...
Case-Based Review
Rheumatoid Arthritis: Therapeutic Strategies After Inadequate Response to Initial TNF Inhibitor Therapy
Conference Coverage
How common is accelerated knee OA?
TORONTO – More than one in seven women who developed knee OA in a large prospective population-based U.K. study had the more severe accelerated...
Conference Coverage
Repeated ANA testing after negative result of little diagnostic value
MADRID – In a retrospective analysis, 79% of repeated antinuclear antibody tests for ANA-associated rheumatologic conditions remained the same....
Conference Coverage
Flu vaccine succeeds in TNF inhibitor users
MADRID – The number needed to vaccinate to prevent one case of influenza among patients taking adalimumab is much lower than it is for healthy...
News
EULAR keeps csDMARDs as top PsA drugs
EULAR’s revised psoriatic arthritis recommendations retain methotrexate and other csDMARDS as first-line treatment over TNF inhibitors.
Conference Coverage
EULAR revises its RA management recommendations
MADRID – Despite some changes, methotrexate remains the first-line drug, and imaging treatment targets remain sidelined.
Conference Coverage
Experts agree on routine lung disease screening in systemic sclerosis
MADRID – Expert management recommendations for interstitial lung disease in systemic sclerosis advise matching frequency of screening to risk.